FDA-Approved vs Supplement Potassium Iodide: What's the Real Difference?
This is the most important distinction in the potassium iodide market — and the one most buyers get wrong. There are only three FDA-approved potassium iodide products in the United States (iOSAT, ThyroSafe, and ThyroShield oral solution). Everything else — regardless of marketing claims — is a dietary supplement operating under completely different regulatory standards.
The Regulatory Divide
| Standard | FDA-Approved Drug | Dietary Supplement |
|---|---|---|
| Approval Pathway | NDA or ANDA (New/Abbreviated Drug Application) | DSHEA (no pre-market approval required) |
| Potency Verification | FDA-verified and monitored | Self-reported by manufacturer |
| Stability Testing | Required FDA stability studies | Not required |
| Manufacturing | FDA-inspected drug GMP | Supplement GMP (less rigorous) |
| Shelf Life | FDA-verified expiration date | Manufacturer-claimed |
| Counterfeit Protection | NDC tracking, DailyMed verification | Limited |
| CDC/FEMA Endorsed | Yes — recommended for emergencies | CDC warns against substitute use |
| Government Stockpiled | Yes (iOSAT is primary) | Never |
| Typical Price/Dose | $0.65–$1.43 | $0.10–$0.20 |
What FDA Approval Actually Means
When a product carries FDA NDA or ANDA approval, it means the manufacturer has submitted clinical data proving the product's safety, efficacy, bioavailability, potency, and stability to the FDA. The FDA then conducts ongoing manufacturing facility inspections and can require recalls if standards slip.
Under DSHEA (the 1994 Dietary Supplement Health and Education Act), supplements do not require pre-market approval. The burden of proof is reversed: the FDA must demonstrate a supplement is unsafe before it can be removed from market. Manufacturers are responsible for their own quality control, but FDA doesn't verify claims before products hit shelves.
The CDC's Position
The CDC has explicitly warned against using dietary supplements as substitutes for FDA-approved KI in radiation emergencies. Daily-use thyroid supplements (typically 225 mcg) contain only 0.17% of the 130,000 mcg (130 mg) emergency dose.
When Supplements Might Be Acceptable
As a secondary stockpile to extend your supply beyond what FDA-approved tablets cover. If you have 14-day FDA-approved coverage and want a backup month of additional supply, the cost savings of supplement KI become meaningful. Just don't make it your only KI supply.